T A Luger
Overview
Explore the profile of T A Luger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
287
Citations
3477
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Agelopoulos K, Rulander F, Dangelmaier J, Lotts T, Osada N, Metze D, et al.
J Eur Acad Dermatol Venereol
. 2019 Aug;
33(12):2371-2379.
PMID: 31442331
Background: Aprepitant is a neurokinin 1 receptor (NK1R) antagonist used for its antipruritic properties in dermatoses and systemic diseases. The mode of action is still unclear. A peripheral effect is...
2.
Ullrich N, Metze D, Luger T, Bohm M
Hautarzt
. 2019 Jun;
70(7):547-549.
PMID: 31161237
No abstract available.
3.
Gkogkolou P, Sarna M, Sarna T, Paus R, Luger T, Bohm M
Br J Dermatol
. 2018 Sep;
180(4):836-848.
PMID: 30171686
Background: Chronic skin ulcers are a major complication and a therapeutic challenge in patients with diabetes mellitus. Glucose-induced accumulation of reactive oxygen species (ROS) is considered to be an important...
4.
Tsianakas A, Luger T, Radin A
Br J Dermatol
. 2017 Aug;
178(2):406-414.
PMID: 28845523
Background: Dupilumab, a human anti-interleukin-4 receptor alpha monoclonal antibody, significantly improved clinical signs and symptoms in adults with moderate-to-severe atopic dermatitis in a randomized, double-blind, placebo-controlled, phase IIa trial. Objectives:...
5.
6.
Schaller M, Schofer H, Homey B, Hofmann M, Gieler U, Lehmann P, et al.
J Dtsch Dermatol Ges
. 2016 Nov;
14 Suppl 6:17-27.
PMID: 27869379
Although there is presently no cure for rosacea, there are several recommended treatment options available to control many of the symptoms and to prevent them from getting worse. In addition...
7.
Reinholz M, Ruzicka T, Steinhoff M, Schaller M, Gieler U, Schofer H, et al.
J Dtsch Dermatol Ges
. 2016 Nov;
14 Suppl 6:4-16.
PMID: 27869378
Rosazea ist eine häufige chronisch-entzündliche Hauterkrankung, die typischerweise bei Erwachsenen vorkommt und das Gesicht betrifft. Synonyme der Rosazea sind Acne rosacea, Kupferfinne, Rotfinne, Couperose und Rosacea. Die Erkrankung ist durch...
8.
Schaller M, Schofer H, Homey B, Gieler U, Lehmann P, Luger T, et al.
J Dtsch Dermatol Ges
. 2016 Nov;
14 Suppl 6:29-37.
PMID: 27869375
Basierend auf den Daten zahlreicher Studien sind orale Tetracycline - und hier insbesondere Doxycyclin als Tetracyclin der zweiten Generation - die Grundpfeiler der systemischen Rosazea-Therapie. Bisher ist dafür jedoch nur...
9.
Schaller M, Schofer H, Homey B, Gieler U, Lehmann P, Luger T, et al.
J Dtsch Dermatol Ges
. 2016 Nov;
14 Suppl 6:29-37.
PMID: 27869374
Based on numerous trials, oral tetracyclines and most commonly their second-generation derivative doxycycline have become the main pillar in systemic rosacea treatment. However, the only preparation that has been approved...
10.
Schaller M, Schofer H, Homey B, Hofmann M, Gieler U, Lehmann P, et al.
J Dtsch Dermatol Ges
. 2016 Nov;
14 Suppl 6:17-28.
PMID: 27869373
Obwohl bislang für die Rosazea keine kurative Therapie besteht, können verschiedene Optionen zur Behandlung der Symptome und zur Vorbeugung von Exazerbationen empfohlen werden. Neben Selbsthilfemaßnahme wie der Vermeidung von Triggerfaktoren...